Patient characteristics
| Age, y/sex . | WBC count, ×109/L . | Hgb level, g/dL . | Plt count, ×109/L . | Cytogenetics . | Path . | IPSS . | Risk . |
|---|---|---|---|---|---|---|---|
| 89/M | 4.6 | 9.2 | 169 | N | CMML | 0 | Low |
| 71/M | 3.9 | 8.1 | 154 | N | RA | 0 | Low |
| 76/M | 6 | 7 | 137 | N | RA | 0 | Low |
| 55/M | 3.4 | 10 | 146 | N | RA | 0 | Low |
| 69/M | 2.1 | 9.6 | 120 | N | RCMD | 0.5 | Int-1 |
| 65/M | 2.4 | 10.8 | 90 | N | RCMD | 0.5 | Int-1 |
| 58/M | 3 | 12 | 106 | N | RA | 0.5 | Int-1 |
| 88/M | 2.4 | 8.3 | 155 | N | RCMD | 0.5 | Int-1 |
| 77/M | 2 | 12 | 174 | N | RCMD | 0.5 | Int-1 |
| 76/M | 5.2 | 9.4 | 41 | t(11:14) | RCMD | 1 | Int-1 |
| 70/M | 4.7 | 12 | 20 | del 20q | RAEB | 1 | Int-1 |
| 78/M | 0.6 | 6 | 30 | del 16 (q22) | RCMD | 1.5 | Int-2 |
| 48/F | 5.2 | 8.4 | 95 | −1q, −11q | RAEB | 1.5 | Int-2 |
| 73/M | 1.2 | 9.4 | 88 | −20q, iso 17q | RCMD | 2 | Int-2 |
| 65/F | 3.1 | 8.3 | 54 | N | RAEB | 1.5 | Int-2 |
| Age, y/sex . | WBC count, ×109/L . | Hgb level, g/dL . | Plt count, ×109/L . | Cytogenetics . | Path . | IPSS . | Risk . |
|---|---|---|---|---|---|---|---|
| 89/M | 4.6 | 9.2 | 169 | N | CMML | 0 | Low |
| 71/M | 3.9 | 8.1 | 154 | N | RA | 0 | Low |
| 76/M | 6 | 7 | 137 | N | RA | 0 | Low |
| 55/M | 3.4 | 10 | 146 | N | RA | 0 | Low |
| 69/M | 2.1 | 9.6 | 120 | N | RCMD | 0.5 | Int-1 |
| 65/M | 2.4 | 10.8 | 90 | N | RCMD | 0.5 | Int-1 |
| 58/M | 3 | 12 | 106 | N | RA | 0.5 | Int-1 |
| 88/M | 2.4 | 8.3 | 155 | N | RCMD | 0.5 | Int-1 |
| 77/M | 2 | 12 | 174 | N | RCMD | 0.5 | Int-1 |
| 76/M | 5.2 | 9.4 | 41 | t(11:14) | RCMD | 1 | Int-1 |
| 70/M | 4.7 | 12 | 20 | del 20q | RAEB | 1 | Int-1 |
| 78/M | 0.6 | 6 | 30 | del 16 (q22) | RCMD | 1.5 | Int-2 |
| 48/F | 5.2 | 8.4 | 95 | −1q, −11q | RAEB | 1.5 | Int-2 |
| 73/M | 1.2 | 9.4 | 88 | −20q, iso 17q | RCMD | 2 | Int-2 |
| 65/F | 3.1 | 8.3 | 54 | N | RAEB | 1.5 | Int-2 |
WBC indicates white blood cell; Hgb, hemmoglobin; Plt, platelet; Path, pathological condition; and CMML, chronic myelomonocytic leukemia